The Clinical Use of N-Acetylcysteine in Gastrointestinal Disorders
Author:
Frye Richard Eugene
Publisher
Springer Singapore
Reference35 articles.
1. Asl SM, Sivandzadeh GR (2011) Efficacy of premedication with activated Dimethicone or N-acetylcysteine in improving visibility during upper endoscopy. World J Gastroenterol 17(37):4213–4217.
https://doi.org/10.3748/wjg.v17.i37.4213
2. Baniasadi S, Eftekhari P, Tabarsi P, Fahimi F, Raoufy MR, Masjedi MR, Velayati AA (2010) Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity. Eur J Gastroenterol Hepatol 22(10):1235–1238.
https://doi.org/10.1097/MEG.0b013e32833aa11b
3. Bernhard MC, Junker E, Hettinger A, Lauterburg BH (1998) Time course of total cysteine, glutathione and homocysteine in plasma of patients with chronic hepatitis C treated with interferon-alpha with and without supplementation with N-acetylcysteine. J Hepatol 28(5):751–755
4. Bromley PN, Cottam SJ, Hilmi I, Tan KC, Heaton N, Ginsburg R, Potter DR (1995) Effects of intraoperative N-acetylcysteine in orthotopic liver transplantation. Br J Anaesth 75(3):352–354
5. Bucuvalas JC, Ryckman FC, Krug S, Alonso MH, Balistreri WF, Kotagal U (2001) Effect of treatment with prostaglandin E1 and N-acetylcysteine on pediatric liver transplant recipients: a single-center study. Pediatr Transplant 5(4):274–278